LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Timepoint Timepoint Unit Mean Total Cell Count Before Treatment Mean Total Cell Count After Treatment Mean Total Control Cell Count Mean Relative Cell Count Mean Relative Growth Rate After Treatment
SK-BR-3 TGX221
10.0
uM
LJP5
 72
hr
 1476 3452 3694 0.9347 0.8911
SK-BR-3 Torin1
10.0
uM
LJP6
 72
hr
 1476 1116 3694 0.3022 -0.1625
SK-BR-3 Torin2
10.0
uM
LJP5
 72
hr
 1476 1128 3694 0.3054 -0.1573
SK-BR-3 Tozasertib
10.0
uM
LJP5
 72
hr
 1476 1328 3694 0.3595 -0.0671
SK-BR-3 Trametinib
10.0
uM
LJP5
 72
hr
 1476 2560 3694 0.6931 0.4887
SK-BR-3 TWS119
10.0
uM
LJP5
 72
hr
 1476 1148 3694 0.3110 -0.1480
SK-BR-3 Vemurafenib
10.0
uM
LJP5
 72
hr
 1476 3200 3694 0.8663 0.7772
SK-BR-3 Withaferin A
10.0
uM
LJP5
 72
hr
 1476 940 3694 0.2546 -0.2419
SK-BR-3 Withaferin A
10.0
uM
LJP6
 72
hr
 1476 989 3694 0.2677 -0.2200
SK-BR-3 WYE-125132
10.0
uM
LJP6
 72
hr
 1476 1510 3694 0.4089 0.0152
SK-BR-3 WZ3105
10.0
uM
LJP5
 72
hr
 1476 1380 3694 0.3738 -0.0433
SK-BR-3 XMD11-50
10.0
uM
LJP6
 72
hr
 1476 1647 3694 0.4459 0.0768
SK-BR-3 Y39983
10.0
uM
LJP6
 72
hr
 1476 1243 3694 0.3366 -0.1053
SK-BR-3 YM 201636
10.0
uM
LJP5
 72
hr
 1476 1748 3694 0.4733 0.1225
SK-BR-3 ZSTK474
10.0
uM
LJP6
 72
hr
 1476 1506 3694 0.4078 0.0134